Website News and Research

RSS

Inhibitex reports Q2 2009 financials

Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.

12 Aug 2009

Upstream Biosciences actively seeking licensors or acquirers for anti-parasitic drug discovery portfolio and cancer diagnostic platform

Upstream Biosciences Inc. (OTCBB: UPBS) has announced that the company is actively seeking licensors or acquirers for its novel anti-parasitic drug discovery portfolio and cancer diagnostic platform.

11 Aug 2009

Taro Pharmaceutical Industries presents preliminary first half 2009 financials

Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today provided information on its financial performance for the first half of 2009

11 Aug 2009

Sorting out the truth in the health care debate

The New York Times reports in a "primer on the details of health reform" that Republican criticism of a government-run insurance plan to compete with private health insurance as "socialized medicine" "seems overblown," it reports. "The Congressional Budget Office has estimated that, under the House bill, the number of people with employer-sponsored insurance would climb to 162 million in 2016, which is 3 million more than expected under current law. Further, it said, enrollment in the proposed public plan might total 11 million, far lower than estimates cited by Republicans."

11 Aug 2009

White House launches website to battle health reform rumors

USA Today reports in The Oval blog that "the White House has rolled out its newest weapon in the cyberwars over health care: A website called Reality Check."

11 Aug 2009

Additional trial to be conducted for KYNAPID under FDA special protocol agreement

Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by the end of 2009, with completion expected in the first half of 2011.

11 Aug 2009

Boston University launches innovative nutrition program for the students, faculty and staff

Boston University College of Health and Rehabilitation Sciences: Sargent College has introduced a new phase of the unique and innovative nutrition program for the students, faculty and staff of Boston University (BU) to enhance the Sargent Choice Healthy Dining Program.

10 Aug 2009

Vion Pharmaceuticals announces ODAC meeting for lead oncology therapeutic Onrigin

Vion Pharmaceuticals (OTC Bulletin Board: VION) today announced the date and location of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which its lead oncology therapeutic Onrigin(TM) (laromustine) Injection will be presented.

10 Aug 2009

At health care town halls, lawmakers try to cope with very opinionated citizens

Town hall meeting fracases continue, as members of Congress 'feel the heat' of very strong opinions on health reform.

10 Aug 2009

Array Biopharma reports Q4 and full year 2009 financials

Array reported revenue of $5.5 million for the fourth quarter of fiscal 2009, compared to revenue of $6.1 million for the same period in fiscal 2008. Array invested $21.3 million in proprietary research and development for the quarter to advance its seven wholly-owned drugs in clinical development and select discovery programs.

10 Aug 2009

Cytori Therapeutics Q2 2009 financial results

Total revenues were $8.5 million and $10.5 million for the three and six months ended June 30, 2009, respectively, compared to $1.4 million and $2.4 million for the same periods in 2008. As part of Cytori’s Olympus partnership, the Company recognized $7.3 million in development revenue in the second quarter of 2009, due mostly to the completion of enrollment in the cardiovascular disease clinical safety and feasibility studies.

From Evident Corporation - Life Sciences 10 Aug 2009

Care Investment Trust announces Q2 2009 financials

Care Investment Trust Inc. (NYSE: CRE) ("Care" or the "Company"), a real estate investment and finance company formed to invest in healthcare-related real estate and commercial mortgage debt, today reported financial results for the second quarter ended June 30, 2009.

10 Aug 2009

Chindex International reports financials for first quarter of fiscal 2010

Chindex International, Inc. (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced results for its first quarter of fiscal 2010, ended June 30, 2009.

10 Aug 2009

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.

6 Aug 2009

Consumer Reports ranks five affiliates of National Surgical Hospitals as "best in state"

National Surgical Hospitals today announced that five of its specialty hospitals achieved the highest rankings among all hospitals in their respective states in the Consumer Reports' Patient Experience of Care Ratings that were published on August 3, 2009.

6 Aug 2009

Expression Analysis launches new look

The url stays the same, but www.ExpressionAnalysis.com looks a lot different today. The redesigned website allows researchers and scientists to more easily navigate and locate the information and services they are looking for, in most cases in just one click. Additionally a revamped search tool enables users to find valuable information on a wide range of scientific topics.

6 Aug 2009

Obama administration takes on opposition attacks, rallies Senate Democrats

President Obama and his Administration launched "a coordinated effort Tuesday to combat what it calls a 'viral whisper campaign' against health reform, Politico reports.

5 Aug 2009

Tips to avoid heat stroke

The first sign of dangerous heat stroke can be just that – no sweat. As the temperature rises, your body’s natural cooling mechanism, sweat (or more kindly, perspiration), evaporates and helps to cool your body. But on those hot, humid cut-the-air-with-a knife days, evaporation is slowed and your body may not be able to keep itself cool.

5 Aug 2009

Website helps caregivers navigate Medicare

The Department of Health and Human Services has created a web site called "Ask Medicare" to help caregivers navigate the often confusing Medicare system.

4 Aug 2009

New journal devoted to gene therapy and human genetics

The Gene Therapy Review was first launched in 2008 as an online source of information on all aspects of gene therapy with sections comprising information on gene therapy research, news, disease targets, patient resources and companies offering services to the gene therapy community. It then further featured a clinical trials database detailing all gene therapy clinical procedures completed to date.

31 Jul 2009